Newsroom

Learn about new clients, partners, research studies, patents, products, FDA clearances, go lives, special events and more by searching our comprehensive library of press releases. We welcome inquires from media.

Study: Patients with COVID-19, Diabetes, Uncontrolled Hyperglycemia Have Significantly Higher Mortality

APRIL 17, 2020 Aislinn Antrim, Assistant Editor Study: Patients with COVID-19, Diabetes, Uncontrolled Hyperglycemia Have Significantly Higher Mortality Although it is already well established that diabetes is a notable risk factor for the coronavirus disease 2019 (COVID-19), new research has found that hospitalized patients with COVID-19, diabetes, and/or uncontrolled hyperglycemia have...
Read More

Diabetes patients at four times greater risk of death from COVID-19

APRIL 17, 2020 Diabetes patients at four times greater risk of death from COVID-19 Diabetic and hyperglycemic patients who contract COVID-19 are more than four times as likely to have complications that result in either death or longer hospital stays than their peers without those co-morbidities, according to a new study. An analysis of more than 1,100 COVID-19 patients hospitalized in 88...
Read More

COVID-19 Study Shows More than 4 Times In-Hospital Mortality Rate and Increased Length of Stay for Patients with Diabetes and Hyperglycemia

Glytec Research Reveals New Insights Into Important Risk Factors for the Large Population of COVID-19 Patients with Glycemic Control Issues WALTHAM, MASS. (April 17, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today published an observational study on the impact of diabetes and uncontrolled hyperglycemia in hospitalized COVID-19 patients. The...
Read More